Amerigen Pharmaceuticals recalls

Amerigen Pharmaceuticals has 4 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 27 Feb 2019. The most frequent reason is potency & assay.

Total recalls4since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 27 Feb 2019

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 4 100%

Why amerigen pharmaceuticals is recalled

Potency & Assay4100%

By year

2019375%
2018125%

All amerigen pharmaceuticals recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
27 Feb 2019Drug	CLASS III	Temozolomide Capsules, 5 mg recalled by Amerigen Pharmaceuticals	Amerigen Pharmaceuticals	Potency & Assay	Nationwide
2 Jan 2019Drug	CLASS III	Temozolomide Capsules, 20 mg recalled by Amerigen Pharmaceuticals	Amerigen Pharmaceuticals	Potency & Assay	NJ
2 Jan 2019Drug	CLASS III	Temozolomide Capsules, 180 mg recalled by Amerigen Pharmaceuticals	Amerigen Pharmaceuticals	Potency & Assay	NJ
24 Oct 2018Drug	CLASS III	Temozolomide capsules, 20 mg recalled by Amerigen Pharmaceuticals	Amerigen Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.